A significant expansion of advanced medical services in the north: New clinics, advanced tests, and greater accessibility for ...

Ocular Therapeutix, Inc. (NASDAQ: OCUL, "Ocular”), an integrated biopharmaceutical company committed to redefining the retina ...

Life Biosciences is pushing cellular rejuvenation into the clinic with ER-100, an experimental gene ...

INDICATIONS EYLEA HD ® (aflibercept) Injection 8 mg is a prescription medicine approved for the treatment of patients with Wet Age-Related Macular Degeneration (AMD), Diabetic Macular Edema (DME), and ...

A Chinese investment fund has claimed that the Beijing government has imposed a prohibition on new investments in ‘Israel’, ...

China’s National Medical Products Administration (NMPA) has granted regulatory approval for 2 next-generation ophthalmic ...

Pakistan Tehreek-e-Insaf founder and former premier Imran Khan received treatment for a retinal condition at Pakistan Institute of Medical Sciences (PIMS) Hospital over the weekend, the hospital's ...

Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory retinoblastoma patients to be presented in an invited session at the 41st Asia-Pacific Academy of ...

Amid controversy surrounding Imran's eye treatment, PIMS had confirmed a day ago that he was taken to the hospital late on the night between Saturday and Sunday, where an anti-VEGF intravitreal ...

Enzeevum, a biosimilar to Eylea, is approved in Canada for multiple retinal conditions, expanding treatment options for ophthalmologists. Biosimilars may offer cost-effective alternatives, potentially ...

Safety and clinical outcomes of Phase 1 study of VCN-01 (zabilugene almadenorepvec) in refractory retinoblastoma patients to be presented in an invited session at the 41st Asia-Pacific Academy of Opht ...

Amid controversy surrounding the eye treatment of Pakistan Tehreek-e-Insaf (PTI) founder Imran Khan, the Pakistan Institute ...